Global Cord Blood (CO) Stock Price, News & Analysis

Company Overview

Global Cord Blood Corporation (NYSE: CO) was a China-based biotechnology and healthcare services company focused on umbilical cord blood banking. Through its operations, the company collected, tested, processed and stored umbilical cord blood for potential use in hematopoietic stem-cell transplantation and related medical applications.

The company provided cord blood preservation services for families, along with laboratory testing, donor-recipient matching and support services associated with cord blood transplantation. Its cord blood banks served customers in selected regions of China, including Beijing, Guangdong province and Zhejiang province, through licensed banking and processing facilities.

Global Cord Blood was formerly known as China Cord Blood Corporation and adopted its Global Cord Blood name in 2020. The business was established in the early 2000s and became publicly listed in the United States in 2009. Publicly available information about its current leadership and operating status is limited, and the company has undergone significant corporate changes since its period as a NYSE-listed issuer.

Key Stats

• Today's Range: $0.95 to $0.95
• 50-Day Range: $0.95 to $0.95
• 52-Week Range: $2.03 to $5.50
• Volume: 2,530 shs
• Average Volume: 216,519 shs
• Market Capitalization: $115.60 million
• P/E Ratio: 1.49
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 6/26/2018
• Today: 10/16/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: NYSE:CO
• CIK: 1467808
• Web: www.globalcordbloodcorp.com
• Phone: (523) 605-8180
• Fax: 852-3605-8181
• Employees: 1,202
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.49
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.24 billion
• Price / Sales: 0.09
• Cash Flow: $0.23 per share
• Price / Cash Flow: 4.19
• Book Value: $6.34 per share
• Price / Book: 0.15

Miscellaneous

• Outstanding Shares: 121,551,000
• Free Float: N/A
• Market Cap: $115.60 million
• Optionable: No Data
• Beta: 0.16